Actavis Laboratories News Today

By Najat Kantouar Indivior said it has reached an agreement with Actavis Laboratories UT to resolve patent disputes regarding Actavis's Abbreviated New Drug...

Indivior PLC (INDV, INDV.L) announced that its subsidiaries Indivior Inc. and Indivior UK, entered into a settlement agreement with Actavis Laboratories UT, a unit of Teva Pharmaceuticals, to resolve patent disputes regarding Actavis's Abbreviated New Drug Application for generic buprenorphine and naloxone sublingual film.

Ticker

Indivior PLC - Richmond, Virginia-based pharmaceutical firm - Says its subsidiaries Indivior Inc and Indivior UK Ltd has agreed on a settlement deal with Actavis Laboratories UT Inc, a subsidiary of...

Fundamental data and tools for long term investing, research and analysis for U.S. stocks, economy and indexes.

Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson's disease drug Neupro, clearing an obstacle for Teva's Actavis Laboratories UT Inc and Viatris' Mylan Technologies Inc to sell generic versions of the drug.

By Blake Brittain (Reuters) - Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Pa...

R&B singer and Pryor Cashman client Chris Brown settled a lawsuit brought by Greensleeves Publishing claiming that Brown's single "Privacy" copied parts of another song.

/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated pharmaceutical company with a robust portfolio of CNS products announced that the U.S. Court of...